烧伤患者多重耐药菌感染对生存与住院时长的影响:回顾性研究
该回顾性研究纳入2012年1月1日至2013年12月31日收治的所有烧伤感染患者,分为多重耐药菌(MDRO)感染组和敏感菌感染组。结果显示MDRO感染与更多手术次数(中位数2 vs 1,P < .0001)、更长机械通气时间(21 vs 0天,P < .0001)、更多抗生素使用天数(21 vs 7天,P < .0001)及更长住院时间(39 vs 14天,P < .0001)相关,但与患者死亡率无关;而>20% TBSA、急性肾损伤、脓毒症和MODS显著增加死亡 odds。
要点
- MDRO感染与更多手术、更长通气和住院时间相关,但不直接增加死亡率。
- >20% TBSA、急性肾损伤、脓毒症和MODS是烧伤患者死亡的显著危险因素。
- MDRO感染组抗生素使用天数中位数21天,显著高于敏感菌组的7天。
核心结论
- MDRO感染与烧伤患者更多手术操作、更长机械通气、更多抗生素使用天数和更长住院时间相关,但与死亡率无独立关联。
研究设计与样本
- 回顾性研究,纳入2012年1月1日至2013年12月31日期间收治的所有烧伤感染患者,分为MDRO感染组和敏感菌感染组。
主要发现
- MDRO组与非耐药组手术操作次数中位数分别为2次和1次(P < .0001)。
- MDRO组与非耐药组机械通气天数分别为21天和0天(P < .0001)。
- MDRO组与非耐药组总抗生素使用天数分别为21天和7天(P < .0001)。
- MDRO组与非耐药组住院时间分别为39天和14天(P < .0001)。
- 单因素logistic回归显示>20% TBSA(OR=4.30,95%CI 1.14-16.29,P = .03)、急性肾损伤(OR=10.93,95%CI 2.74-43.57,P = .001)、脓毒症(OR=19.20,95%CI 3.79-97.27,P < .001)和MODS(OR=85.49,95%CI 12.97-563.28,P < .0001)显著增加患者死亡 odds。
关键数值与推荐
- MDRO感染组手术操作次数中位数2次 vs 非耐药组1次,P < .0001。
- MDRO感染组机械通气天数21天 vs 非耐药组0天,P < .0001。
- MDRO感染组总抗生素天数21天 vs 非耐药组7天,P < .0001。
- MDRO感染组住院时间39天 vs 非耐药组14天,P < .0001。
- >20% TBSA、急性肾损伤、脓毒症和MODS的死亡 odds 分别为OR=4.30(95%CI 1.14-16.29,P = .03)、OR=10.93(95%CI 2.74-43.57,P = .001)、OR=19.20(95%CI 3.79-97.27,P < .001)、OR=85.49(95%CI 12.97-563.28,P < .0001)。
临床怎么用
- 对烧伤MDRO感染患者应预期更长的住院时间、更多的抗生素使用天数和手术干预需求。
- 烧伤患者出现>20% TBSA、急性肾损伤、脓毒症或MODS时需警惕死亡风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite improvements in early treatment, survival following burn injury remains challenged by sepsis and multiple organ dysfunction syndrome (MODS). Additionally, susceptibility to infections and growing antibiotic resistance places burn patients at increased risk for infections with multiple-drug resistant organisms (MDROs). We therefore aimed to evaluate the impact of MDRO infections on survival and hospital length of stay, as well as examine the role of these organisms in the development of complications, such as acute kidney injury, sepsis, and MODS. To study this, we included all burn patients with infections, admitted between January 1, 2012, and December 31, 2013. Patients were divided into two groups: patients with infections caused by MDROs and patients with infections caused by susceptible organisms. Data were collected on all available cultures, as well as demographic, injury, and treatment-related variables from the medical record. The number of operative procedures (median: 2 vs 1, P < .0001), ventilator days (21 vs 0 days, P < .0001), total antibiotic days (21 vs 7days, P < .0001), and length of hospitalization (39 vs 14 days, P < .0001) were significantly different in the MDRO group vs the nonresistant group. While MDRO infection was not associated with patient mortality, univariable logistic regression analyses demonstrated >20% TBSA (odds ratio [OR] = 4.30, 95% confidence interval [CI]: 1.14-16.29, P = .03), acute kidney injury (OR = 10.93, 95% CI: 2.74-43.57, P = .001), sepsis (OR = 19.20, 95% CI: 3.79-97.27, P < .001), and MODS (OR = 85.49, 95% CI: 12.97-563.28, P < .0001) significantly increased the odds of patient mortality. These findings suggest that infections with MDROs are associated with a greater number of surgical procedures, longer duration of mechanical ventilation, more antibiotic days, and longer hospitalization.
引用
- van Langeveld I, Gagnon RC, Conrad PF, et al. Multiple-Drug Resistance in Burn Patients: A Retrospective Study on the Impact of Antibiotic Resistance on Survival and Length of Stay. J Burn Care Res. 2017. PMID: 27984411. doi:10.1097/BCR.0000000000000479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。